HEALTH

FDA approves new version of Mounjaro for weight loss

Nov 8, 2023, 12:26 PM | Updated: Nov 9, 2023, 1:34 pm

The Eli Lilly & Co. corporate headquarters are seen in Indianapolis on April 26, 2017....

FILE - The Eli Lilly & Co. corporate headquarters are seen in Indianapolis on April 26, 2017. This week, the U.S. Food and Drug Administration approved Eli Lilly's Zepbound, or tirzepatide, a drug that helped dieters lose about a quarter of their body weight (Darron Cummings, Associated Press)

(Darron Cummings, Associated Press)

A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.

A deep dive into weight-loss drugs:

 

The U.S. Food and Drug Administration approved Eli Lilly’s Zepbound, or tirzepatide. The drug helped dieters lose about a quarter of their body weight, or 60 pounds (27 kilograms), in a recent study.

Zepbound is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic.

The FDA approved Lilly’s drug for people who are considered obese, with a body mass index of 30 or higher, or those who are overweight with a related health condition, like high blood pressure, high cholesterol or diabetes. The drug should be paired with a healthy diet and regular exercise, the FDA said.

In the U.S., at least 100 million adults and about 15 million children are considered obese.

The drug tirzepatide in Zepbound and Mounjaro and semaglutide in Wegovy and Ozempic work by mimicking hormones that kick in after people eat to regulate appetite and the feeling of fullness. Both imitate a hormone called glucagon-like peptide-1, known as GLP-1. Tirzepatide targets a second hormone, called glucose-dependent insulinotropic polypeptide, or GIP.

Zepbound appears to spur greater weight loss than Wegovy. Approved for chronic weight management in 2021, Wegovy helped people lose about 15% of their body weight or 34 pounds (15.4 kilograms), according to study results.

“This would be the most highly efficacious drug ever approved for the treatment of obesity,” said Dr. Fatima Cody Stanford, an obesity medicine expert at Massachusetts General Hospital in Boston.

Touted by celebrities and on social media, semaglutide and tirzepatide drugs have already been in such demand that their manufacturers have struggled to keep up. Both have been listed on the FDA’s drug shortage site for months. All strengths of tirzepatide are currently listed as available, but a company spokesperson said that could vary by location and demand.

Side effects of the new weight-loss drug include vomiting, nausea, diarrhea, constipation and other gastrointestinal problems. In the most recent published trial, about 10% of people taking tirzepatide dropped out of the study because of such problems, compared to about 2% of people taking dummy shots.

While experts lauded approval of Zepbound, they worried that it wouldn’t necessarily mean greater access to the drug, which has been prescribed “off-label” to help people pare pounds.

“Most patients won’t be able to afford Zepbound without insurance coverage and many health plans exclude obesity care,” said Dr. Katherine Saunders, an obesity expert at New York’s Weill Cornell Medicine and co-founder of company focused on obesity treatment.

Eli Lilly and Co. said the list price for will be about $1,000 a month, the same as Mounjaro. Medicare is prohibited from covering drugs specifically for weight loss.

Kelly Burns, 50, of St. Petersburg, Florida, lost nearly 100 pounds (45 kilograms) using tirzepatide after joining a study of the drug to treat obesity in 2021. When testing ended and she no longer had access to the medication, she struggled, but eventually lost another 50 pounds (23 kilograms).

“My whole life is completely different,” she said. Her health measurements improved and her confidence soared. Now that is approved for weight loss, Burns plans to ask her insurance company about coverage. “It would be ridiculous not to,” she said, adding: “I want to stay this way as long as I possibly can.”
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

We want to hear from you.

Have a story idea or tip? Send it to the KSL NewsRadio team here.

Health

Khloee Camberlango after receiving a surgery for her scoliosis....

Angie Denison

Khloee’s journey: Overcoming scoliosis with courage and cheer

Khloee Camberlango was diagnosed with scoliosis at the age of nine. She had to proceed to go through braces and surgery to aid the scoliosis.

3 hours ago

A photo taken of Matthew Perry in 2022....

Clayre Scott

Criminal investigation opened in relation to Matthew Perry’s death

A criminal investigation has been opened in relation to Matthew Perry's death due to high levels of ketamine found in his blood.

14 hours ago

Former U.S. President Jimmy Carter and his wife, former first lady Rosalynn Carter, sit together du...

Curt Gresseth

Healthy marriages good for Utah taxpayers, says governor’s adviser

An adviser to Utah Gov. Spencer Cox says state government is invested in and promotes the importance of strong, healthy marriages and families.

15 hours ago

West High Principal Jared Wright with James Yapias in front of west high clinic sign...

Amanda Dickson

Healthcare inside West High School

The West High School Clinic allows students to see nurses, pediatricians, psychiatrists and psychologists right inside their school.

2 days ago

Jared Dangerfield, Wasatch Adaptive Sports program manager, skis with retired United States Marine ...

Michael Camit

Up to a quarter of Utahns struggle with disabilities, report says

According to a report from the Kem C. Gardner Policy Institute, up to a quarter of Utahns struggle with a disability.

2 days ago

BYU nursing student Jane Pearson smiles before donating her bone marrow in late 2023....

Emma Everett Johnson, KSL.COM

BYU student donates bone marrow to potentially save stranger’s life

BYU nursing student Jane Pearson is donating bone marrow to a stranger through the National Marrow Donor Program.

2 days ago

Sponsored Articles

a doctor putting her hand on the chest of her patient...

Intermountain Health

Intermountain nurse-midwives launch new gynecology access clinic

An access clinic launched by Intermountain nurse-midwives provides women with comprehensive gynecology care.

Young couple hugging while a realtor in a suit hands them keys in a new home...

Utah Association of Realtors

Buying a home this spring? Avoid these 5 costly pitfalls

By avoiding these pitfalls when buying a home this spring, you can ensure your investment will be long-lasting and secure.

a person dressed up as a nordic viking in a dragon boat resembling the bear lake monster...

Bear Lake Convention and Visitors Bureau

The Legend of the Bear Lake Monster

The Bear Lake monster has captivated people in the region for centuries, with tales that range from the believable to the bizarre.

...

Live Nation Concerts

All the artists coming to Utah First Credit Union Amphitheatre (formerly USANA Amp) this summer

Summer concerts are more than just entertainment; they’re a celebration of life, love, and connection.

Mother and cute toddler child in a little fancy wooden cottage, reading a book, drinking tea and en...

Visit Bear Lake

How to find the best winter lodging in Bear Lake, Utah

Winter lodging in Bear Lake can be more limited than in the summer, but with some careful planning you can easily book your next winter trip.

Happy family in winter clothing at the ski resort, winter time, watching at mountains in front of t...

Visit Bear Lake

Ski more for less: Affordable ski resorts near Bear Lake, Utah

Plan your perfect ski getaway in Bear Lake this winter, with pristine slopes, affordable tickets, and breathtaking scenery.

FDA approves new version of Mounjaro for weight loss